{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:01:00Z","timestamp":1781164860309,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.brachy.2025.09.015","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:26:05Z","timestamp":1761654365000},"page":"182-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CT-guided high-dose-rate interstitial brachytherapy for malignant lung lesions in a resource-limited setting"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-4318","authenticated-orcid":false,"given":"Simit","family":"Sapkota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-5194","authenticated-orcid":false,"given":"Subhas","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Suwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeebana","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0985-0197","authenticated-orcid":false,"given":"Abish","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerim","family":"Prasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjani Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.09.015_bib0001","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1470-2045(09)70103-2","article-title":"Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials","volume":"10","author":"Powell","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0002","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1016\/j.cllc.2018.06.001","article-title":"Ultracentral tumors treated with stereotactic body radiotherapy: single-institution experience","volume":"19","author":"Raman","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.brachy.2025.09.015_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.21037\/atm-21-6256","article-title":"Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.brachy.2025.09.015_bib0004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijrobp.2023.02.024","article-title":"Challenges to improving access to stereotactic body radiation therapy and radiosurgery in the Philippines: A case study for lower-middle income countries","volume":"116","author":"Cruz-Lim","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.015_bib0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.brachy.2021.03.012","article-title":"Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature","volume":"20","author":"Ferentinos","year":"2021","journal-title":"Brachytherapy"},{"issue":"Suppl 2","key":"10.1016\/j.brachy.2025.09.015_bib0006","doi-asserted-by":"crossref","first-page":"S807","DOI":"10.4103\/jcrt.jcrt_1351_22","article-title":"Percutaneous high-dose-rate interstitial brachytherapy for non-resectable, chemo resistant malignant lesion of lung and liver","volume":"19","author":"Yadawa","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.brachy.2025.09.015_bib0007","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.07.1700","article-title":"Computed tomography\u2013guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival","volume":"78","author":"Mohnike","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.015_bib0008","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/JTO.0b013e318208c7a3","article-title":"Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies","volume":"6","author":"Tselis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0009","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00066-006-1536-6","article-title":"High-dose-rate brachytherapy for small-sized peripherally located lung cancer","volume":"182","author":"Imamura","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non\u2013small-cell lung cancer: what we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0011","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","article-title":"A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927)","volume":"93","author":"Videtic","year":"2015","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.brachy.2025.09.015_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13014-021-01826-1","article-title":"Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation","volume":"16","author":"Yoon","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0013","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00066-021-01758-5","article-title":"Interstitial single fraction brachytherapy for malignant pulmonary tumours","volume":"197","author":"Rashid","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0014","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.brachy.2019.08.001","article-title":"Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience","volume":"18","author":"Chatzikonstantinou","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.015_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejrad.2018.10.008","article-title":"Primary and metastatic malignancies of the lung: retrospective analysis of the CT-guided high-dose rate brachytherapy (CT-HDRBT) ablation in tumours <4 cm and \u22654 cm","volume":"108","author":"Jonczyk","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0016","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5114\/jcb.2018.79230","article-title":"Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma","volume":"10","author":"Omari","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.015_bib0017","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ijrobp.2015.04.019","article-title":"Computed tomography\u2013guided interstitial high-dose-rate brachytherapy in combination with regional positive lymph node intensity-modulated radiation therapy in locally advanced peripheral non\u2013small cell lung cancer: A phase 1 clinical trial","volume":"92","author":"Xiang","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.015_bib0018","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0973-1482.82914","article-title":"Computerized tomography-guided percutaneous high-dose-rate interstitial brachytherapy for malignant lung lesions","volume":"7","author":"Sharma","year":"2011","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.brachy.2025.09.015_bib0019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00066-008-1718-5","article-title":"CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial","volume":"184","author":"Peters","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1378\/chest.127.6.2237","article-title":"CT-guided interstitial single-fraction brachytherapy of lung tumors","volume":"127","author":"Ricke","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.brachy.2025.09.015_bib0021","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2025.09.015_bib0022","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2025.09.015_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5114\/jcb.2024.139103","article-title":"Salvage percutaneous high-dose-rate brachyablation after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"16","author":"Wu","year":"2024","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.015_bib0024","series-title":"Manual on image-guided brachytherapy of inner organs","first-page":"153","article-title":"CT-guided interstitial HDR brachytherapy for malignant lung lesions: experience from University of California Los Angeles","author":"Yoon","year":"2021"},{"key":"10.1016\/j.brachy.2025.09.015_bib0025","series-title":"Manual on image-guided brachytherapy of inner organs","first-page":"135","article-title":"Lung brachytherapy: experience from Germany","author":"Peters","year":"2021"},{"key":"10.1016\/j.brachy.2025.09.015_bib0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5114\/jcb.2025.148297","article-title":"Diaphragm and lung dose in liver high-dose-rate interstitial brachytherapy: a dosimetry and toxicity report","volume":"17","author":"Yogabalan","year":"2025","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.015_bib0027","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2214\/AJR.21.27099","article-title":"Update on image-guided thermal lung ablation: society guidelines, therapeutic alternatives, and postablation imaging findings","volume":"219","author":"Murphy","year":"2022","journal-title":"AJR Am J Roentgenol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:39:23Z","timestamp":1781163563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538472125003150"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.09.015","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CT-guided high-dose-rate interstitial brachytherapy for malignant lung lesions in a resource-limited setting","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}